1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ici 192605 in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ici 192605) | Trials (ici 192605) | Recent Studies (post-2010) (ici 192605) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 35 | 2 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, PJ; Chung, KF; Lötvall, JO; Morikawa, A; Tokuyama, K | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ici 192605
Article | Year |
---|---|
Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor.
Topics: Administration, Inhalation; Airway Resistance; Animals; Blood Pressure; Capillary Permeability; Dioxanes; Female; Guinea Pigs; Histamine; Methacrylates; Microcirculation; Platelet Activating Factor; Receptors, Prostaglandin; Receptors, Thromboxane; Respiratory System; Thromboxane A2; Thromboxane-A Synthase | 1991 |